Mapping the Specter: Seeing Asking for It as Spectral Realism
Language, Literature, and Interdisciplinary Studies · 2018
DOI: 10.71106/cngl8282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Language, Literature, and Interdisciplinary Studies, 2018. Verfasst von Marybeth Ragsdale-Richards. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper argues that O’Neill intentionally adopts the traditional standards of patriarchal poetics in Asking for It to underscore the immediacy of dispelling rape myths. To this effect, feminist visual culture studies have been utilized to draw attention to the way O’Neill antagonizes the male gaze—and thus the spectator’s gaze—in Emma’s self-fashioning and in the sexual violence that the rapist perpetrates against her. Even though fetishistic scopophilia and sadistic voyeurism drive the plot forward, O’Neill’s text actively resists the pleasure in looking, as the masculine ego ideal of the male “hero” requires readers to identify with the gaze of the rapists. Consequently, Asking for It is an instance of spectral realism, wherein Emma’s first-person narration of the rape creates the effect that readers are spectators complicit in the assault and contribute to her capitulation. This paper contends that Asking for It is a text that feminist literary scholars and teachers can utilize to pathologize the post-modern young adult novel.
Zitieren
APA
Ragsdale-Richards, M. (2018). Mapping the Specter: Seeing Asking for It as Spectral Realism. Language, Literature, and Interdisciplinary Studies. https://doi.org/10.71106/cngl8282
Vancouver
Ragsdale-Richards M. Mapping the Specter: Seeing Asking for It as Spectral Realism. Language, Literature, and Interdisciplinary Studies. 2018. doi:10.71106/cngl8282
BibTeX
@article{RagsdaleRichards2018,
author = {Ragsdale-Richards, Marybeth},
title = {Mapping the Specter: Seeing Asking for It as Spectral Realism},
journal = {Language, Literature, and Interdisciplinary Studies},
year = {2018},
doi = {10.71106/cngl8282}
}
EUVIMED